Evidence map›Paper›PMID 23729734›Full record

ArticleJournal of cell science2013

TEM4 is a junctional Rho GEF required for cell-cell adhesion, monolayer integrity and barrier function.

Siu P Ngok, Rory Geyer, Antonis Kourtidis, Natalia Mitin, Ryan Feathers, Channing Der, Panos Z Anastasiadis

Open access · bronzeAbstract read
In one paragraph

Article in Journal of cell science, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 47 citations in OpenAlex.

  1. Article
  2. Biology, Physics, and Genetics of Intracranial Aneurysm Formation: A Review.Journal of neurological surgery. Part A, Central European neurosurgery · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Tumor necrosis factor-induced ArhGEF10 selectively activates RhoB contributing to human microvascular endothelial cell tight junction disruption.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2021
    Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Rare and Low-Frequency Variant ofCirculation. Genomic and precision medicine · 2018
    Article
  16. Rho Guanine Nucleotide Exchange FactorCirculation. Genomic and precision medicine · 2018
    Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 6 institutions in 1 country.

Siu P NgokDepartment of Cancer Biology, Mayo Clinic Comprehensive Cancer Center, Griffin Cancer Research Building, Room 307, 4500 San Pablo Road, Jacksonville, FL 32224, USA.
Rory Geyer
Antonis Kourtidis
Natalia Mitin
Ryan Feathers
Channing Der
Panos Z Anastasiadis
University of North Carolina at Chapel Hill · USJacksonville College · USMayo Clinic · USMayo Clinic in Florida · USUNC Lineberger Comprehensive Cancer CenterWinnMed · US

Funding

Combining Anti-Invasive and Anti-Angiogenic Therapies for the treatment of GBMR01NS069753 · NINDS · MAYO CLINIC JACKSONVILLE · PI ANASTASIADIS, PANAGIOTIS Z. · 2010 to 2014
$1.6M
Role of the polarity RhoGEF PLEKHG5 on brain tumor dispersalR21NS070117 · NINDS · MAYO CLINIC JACKSONVILLE · PI ANASTASIADIS, PANAGIOTIS Z. · 2010 to 2011
$417k
NINDS NIH HHS R01 NS069753NINDS NIH HHS R21 NS070117
6 · The paper itself

Abstract

Signaling events mediated by Rho family GTPases orchestrate cytoskeletal dynamics and cell junction formation. The activation of Rho GTPases is tightly regulated by guanine-nucleotide-exchange factors (GEFs). In this study, we identified a novel Rho-specific GEF called TEM4 (tumor endothelial marker 4) that associates with multiple members of the cadherin-catenin complex and with several cytoskeleton-associated proteins. Depending on confluence, TEM4 localized to either actin stress fibers or areas of cell-cell contact. The junctional localization of TEM4 was independent of actin binding. Depletion of endogenous TEM4 by shRNAs impaired Madin-Darby canine kidney (MDCK) and human umbilical vein endothelial cell (HUVEC) cell junctions, disrupted MDCK acini formation in 3D culture and negatively affected endothelial barrier function. Taken together, our findings implicate TEM4 as a novel and crucial junctional Rho GEF that regulates cell junction integrity and epithelial and endothelial cell function.

Indexed as

AnimalsCell AdhesionCytoskeletonDogsGuanine Nucleotide Exchange FactorsHEK293 CellsHumansHuman Umbilical Vein Endothelial CellsMadin Darby Canine Kidney CellsRho Guanine Nucleotide Exchange FactorsSignal TransductionARHGEF17 protein, humanGuanine Nucleotide Exchange FactorsRho Guanine Nucleotide Exchange FactorsCateninCell adhesionCell junctionGuanine nucleotide exchange factorRhoATEM4

Identifiers

PMID23729734
PMCPMC3730241
OpenAlexW2053639713

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.